Clinical rationale for rosuvastatin, a potent new HMG-CoA reductase inhibitor. [electronic resource]
Producer: 20010927Description: 399-405 p. digitalISSN:- 1368-5031
No physical items for this record
Publication Type: Journal Article; Review
There are no comments on this title.
Log in to your account to post a comment.